|
2889
|
VA012
|
Positive allosteric modulator (PAM) of 5-HT2C receptor |
Recently added
|
€105.00 |
|
2106
|
Valdecoxib
|
Selecive COX-2 inhibitor |
€80.00 |
|
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€55.00 |
|
1384
|
Varenicline dihydrochloride
|
Nicotinic acetylcholine receptor agonist |
€85.00 |
|
2074
|
Varenicline tartrate
|
Selective α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist |
€90.00 |
|
1867
|
Vasopressin antagonist 1867
|
Orally available and selective V1b receptor antagonist |
€125.00 |
|
1637
|
Vatalanib
|
VEGFR tyrosine kinase inhibitor |
€75.00 |
|
1893
|
VE 821
|
Inhibitor of the DNA damage response kinase ATR |
€95.00 |
|
2452
|
VE 822
|
Selective ATR inhibitor that decreases survival of pancreatic cancer cells |
€110.00 |
|
1727
|
Venlafaxine hydrochloride
|
SNRI |
€65.00 |
|
1608
|
VER 155008
|
Hsp70 inhibitor |
€95.00 |
|
2685
|
Vercirnon
|
CCR9 antagonist |
€135.00 |
|
2938
|
Verinurad
|
Highly potent and selective inhibitor of the renal urate transporter URAT1 |
€95.00 |
|
2810
|
VH298
|
Inhibitor of E3 ubiquitin-protein ligase VHL |
€135.00 |
|
2377
|
Vidofludimus
|
Oral immunomodulatory drug that inhibits dihydroorotate dehydrogenase (DHODH) |
€125.00 |